10.69  0.01 (0.09%)		04-28 12:29
Open: 10.69 High: 10.69 Volume: 2		Pre. Close: 10.68 Low: 10.69 Market Cap: 263(M)

Short term
Mid term
Targets	6-month :	12.49	1-year :	14.59
Resists	First :	10.69	Second :	12.49
Pivot price	10.64
Supports	First :	10.59	Second :	10.53
MAs	MA(5) :	10.64	MA(20) :	10.62
	MA(100) :	10.63	MA(250) :	10.55
MACD	MACD :	0	Signal :	-0.1
%K %D	K(14,3) :	69.4	D(3) :	66.6
RSI	RSI(14): 54.3
52-week	High :	10.73	Low :	10.3

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ OACC ] has closed below upper band by 16.9%. Bollinger Bands are 13.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	10.62 - 10.68	10.68 - 10.73
Low:	10.43 - 10.5	10.5 - 10.57
Close:	10.47 - 10.57	10.57 - 10.68

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Mon, 27 Apr 2026
Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Short Interest Down 45.5% in April - MarketBeat

Sun, 12 Apr 2026
JPMorgan Chase & Co. Cuts Holdings in Oaktree Acquisition Corp. III Life Sciences $OACC - MarketBeat

Wed, 08 Apr 2026
What is the future of Oaktree (OACC) Stock | Price at $10.65, Up 0.57% - Price Momentum - UBND thành phố Hải Phòng

Thu, 26 Mar 2026
Oaktree Acquisition III Life Sciences reports $0 revenue, net income $7.29M - TradingView

Fri, 17 Oct 2025
Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director - Investing.com

Tue, 19 Aug 2025
Aman Kumar Net Worth (2026) - GuruFocus

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	20 (M)
Shares Float	18 (M)
Held by Insiders	0 (%)
Held by Institutions	90.4 (%)
Shares Short	50 (K)
Shares Short P.Month	50 (K)

EPS	0.3
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.29
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-0.4 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	35.63
PEG Ratio	0
Price to Book value	-38.18
Price to Sales	0
Price to Cash Flow	-500.97

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.